A5047724670- Prostate Cancer Diagnosis and Treatment
- Urologic and reproductive health conditions
- Prostate Cancer Treatment and Research
- MRI in cancer diagnosis
- Vascular Malformations and Hemangiomas
- Renal cell carcinoma treatment
Royal Free London NHS Foundation Trust
2023
University College London
2023
Royal London Hospital
2023
Whipps Cross University Hospital
2023
Barts Health NHS Trust
2023
Background High variability in prostate MRI quality might reduce accuracy cancer detection. Purpose To prospectively evaluate the of scanners taking part control phase global PRIME (Prostate Imaging Using ± Contrast Enhancement) trial using Prostate Quality (PI-QUAL) standardized scoring system, give recommendations on how to improve protocols, and establish whether could be improved by these recommendations. Materials Methods In prospective clinical (PRIME), for each scanner, centers...
Background The optimal diagnostic pathway for prostate cancer (PCa) is evolving, requiring further evaluation in a randomized controlled trial. Purpose To assess the accuracy of prebiopsy multiparametric MRI identification clinically significant PCa (csPCa) using radical prostatectomy (RP) specimens as reference standard, and to test combined US fusion–targeted biopsy with systematic biopsies. Materials Methods In prospective trial including university hospitals, men suspected were recruited...
Journal Article Blue rubber bleb naevus syndrome: an unusual cause of urethral bleeding Get access J.R. Wilson, Wilson Pyrah Department Urology and Search for other works by this author on: Oxford Academic Google Scholar M.J. Weston, Weston Radiology, St James’ University Hospital, Leeds LS9 7TF, U.K. Correspondence: J.R.Wilson, Bradford Royal Infirmary, Duckworth Lane, BD10 0ET, E‐mail: wilson_russ@yahoo.co.uk P. Singh, Singh I. Eardley British Dermatology, Volume 143, Issue 3, 1 September...